
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Analysis of [RARE] Ultragenyx Pharmaceutical Inc
Data updated 2025-Jul-14 (Monday)Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab

Share
2025-Jul-14 Monday
Open | $28.53 | High | $30.17 +5.75% |
---|---|---|---|
Close | $29.23 | Low | $28.35 -0.63% |
Volume | 4.19 Million 1.68x | Volatility | 6.42% |
Change |
$-0.28
-0.95%
|
Streak | ↓ 3 days -29.46% |
20d SMA | $36.65 -20.3% | 50d SMA | $36.39 -19.7% | 100d SMA | $37.23 -21.5% | 200d SMA | $42.56 -31.3% |
RSI | 30 | MACD | -0.99 | ADX | 21.1 | Stochastic Oscillator | 8.3 35.1 |
CCI | -244.9 | ATR | 2.33 | OBV | 1.23 Million | Chaikin A/D | 21.1 Million |
Market Cap | 2.79 B | PEG Ratio | -0.24 | Trailing P/E | Forward P/E | 0 | |
Price/Sales (ttm) | 4.72 | Price/Book (mrq) | 19.3 | EV/Revenue (ttm) | 3.95 | EV/EBITDA (ttm) | -6.46 |
% Held by Insiders | 3.20% | % Held by Institutions | 98.45% | Shares Short | 3.78 M | Shares Short (prior month) | 3.56 M |
Short Ratio | 4.87 | Short % of Outstanding | 4.00% | Short % of Float | 4.15% | Shares Short Change (mom) | +6.2% |
Revenue/Share (ttm) | $6.32 | Profit Margin (ttm) | -93.00% | Operating Margin (ttm) | -102.60% | EBITDA (ttm) | -478 M |
Diluted EPS (ttm) | $-5.83 | Current Ratio (mrq) | 2.61 | Return on Assets (ttm) | -24.50% | Return on Equity (ttm) | -377.10% |
Qtr Earnings Growth (yoy) | 0.00% | Qtr Revenue Growth (yoy) | 28.00% | Operating Cash Flow (ttm) | -475 M | Free Cash Flow (ttm) | -283 M |
Choose view type
Monthly Performance for Ultragenyx Pharmaceutical Inc. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)
Note: Performance over Key Timeperiods for Ultragenyx Pharmaceutical Inc up to close of 2025-Jul-14 at $29.23
3-month Performance Benchmarks for Ultragenyx Pharmaceutical Inc:
Related to Ultragenyx Pharmaceutical Inc
Information for Ultragenyx Pharmaceutical Inc
Current Detail : Recent daily/monthly performance & benchmark comparison Currently Viewing
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Jul-14 on Google
SEC Reports : Quarterly reports around 2025-Jul-14 on SEC Edgar
Compare Ultragenyx Pharmaceutical Inc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Ultragenyx Pharmaceutical Inc
Industry : Biotechnology industry performance which includes Ultragenyx Pharmaceutical Inc